Stokes Family Office’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Sell |
726
-21
| -3% | -$8.52K | 0.03% | 201 |
|
|
2025
Q1 | $372K | Sell |
747
-42
| -5% | -$20.9K | 0.04% | 182 |
|
|
2024
Q4 | $410K | Buy |
+789
| New | +$410K | 0.04% | 177 |
|
|
2023
Q4 | – | Sell |
-1,196
| Closed | -$605K | – | 333 |
|
|
2023
Q3 | $605K | Buy |
1,196
+56
| +5% | +$28.3K | 0.07% | 168 |
|
|
2023
Q2 | $595K | Sell |
1,140
-52
| -4% | -$27.1K | 0.07% | 159 |
|
|
2023
Q1 | $687K | Buy |
1,192
+171
| +17% | +$98.6K | 0.09% | 141 |
|
|
2022
Q4 | $562K | Sell |
1,021
-255
| -20% | -$140K | 0.07% | 150 |
|
|
2022
Q3 | $647K | Buy |
1,276
+178
| +16% | +$90.3K | 0.09% | 134 |
|
|
2022
Q2 | $597K | Buy |
1,098
+65
| +6% | +$35.3K | 0.08% | 147 |
|
|
2022
Q1 | $610K | Sell |
1,033
-119
| -10% | -$70.3K | 0.08% | 148 |
|
|
2021
Q4 | $769K | Buy |
1,152
+21
| +2% | +$14K | 0.1% | 122 |
|
|
2021
Q3 | $646K | Buy |
1,131
+21
| +2% | +$12K | 0.09% | 127 |
|
|
2021
Q2 | $560K | Buy |
1,110
+53
| +5% | +$26.7K | 0.08% | 131 |
|
|
2021
Q1 | $505K | Buy |
1,057
+90
| +9% | +$43K | 0.08% | 130 |
|
|
2020
Q4 | $450K | Buy |
+967
| New | +$450K | 0.09% | 116 |
|